GSK PLC (GSK)
40.72
-0.52
(-1.27%)
USD |
NYSE |
Apr 24, 11:56
GSK Total Assets (Quarterly): 75.17B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.17B |
| September 30, 2023 | 74.26B |
| June 30, 2023 | 75.00B |
| March 31, 2023 | 72.57B |
| December 31, 2022 | 72.79B |
| September 30, 2022 | 67.35B |
| June 30, 2022 | 108.00B |
| March 31, 2022 | 117.82B |
| December 31, 2021 | 106.76B |
| September 30, 2021 | 105.66B |
| June 30, 2021 | 106.58B |
| March 31, 2021 | 107.32B |
| December 31, 2020 | 109.61B |
| September 30, 2020 | 104.10B |
| June 30, 2020 | 104.18B |
| March 31, 2020 | 104.38B |
| December 31, 2019 | 104.49B |
| September 30, 2019 | 102.32B |
| June 30, 2019 | 80.64B |
| March 31, 2019 | 81.34B |
| December 31, 2018 | 73.68B |
| September 30, 2018 | 76.36B |
| June 30, 2018 | 75.35B |
| March 31, 2018 | 78.71B |
| December 31, 2017 | 76.19B |
| Date | Value |
|---|---|
| September 30, 2017 | 78.94B |
| June 30, 2017 | 75.76B |
| March 31, 2017 | 73.91B |
| December 31, 2016 | 72.58B |
| September 30, 2016 | 76.21B |
| June 30, 2016 | 77.58B |
| March 31, 2016 | 78.29B |
| December 31, 2015 | 79.18B |
| September 30, 2015 | 80.50B |
| June 30, 2015 | 85.10B |
| March 31, 2015 | 85.88B |
| December 31, 2014 | 63.27B |
| September 30, 2014 | 65.45B |
| June 30, 2014 | 66.17B |
| March 31, 2014 | 66.09B |
| December 31, 2013 | 69.40B |
| September 30, 2013 | 66.46B |
| June 30, 2013 | 64.16B |
| March 31, 2013 | 65.18B |
| December 31, 2012 | 67.03B |
| September 30, 2012 | 65.65B |
| June 30, 2012 | 65.88B |
| March 31, 2012 | 65.10B |
| December 31, 2011 | 63.30B |
| September 30, 2011 | 64.58B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
67.35B
Minimum
Sep 2022
117.82B
Maximum
Mar 2022
94.68B
Average
104.18B
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 101.12B |
| Haleon PLC | 43.38B |
| Novo Nordisk A/S | 46.69B |
| Pfizer Inc | 226.50B |
| Sanofi SA | 139.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.87B |
| Shareholders Equity (Quarterly) | 17.00B |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 0.8849 |
| Net Debt Paydown Yield | 0.87% |